Evidence map›Paper›PMID 25391905›Full record

ArticleEMBO reports2014

Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β-catenin signalling.

Qing Chen, Yi Su, Janine Wesslowski, Anja I Hagemann, Mirana Ramialison, Joachim Wittbrodt, Steffen Scholpp, Gary Davidson

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 43 citations in OpenAlex.

  1. MTSS1: beyond the integration of actin and membrane dynamics.Cellular and molecular life sciences : CMLS · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Cells · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. LRPs in WNT Signalling.Handbook of experimental pharmacology · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Qing ChenInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Yi SuInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Janine WesslowskiInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Anja I HagemannInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Mirana RamialisonCOS Heideberg, Heidelberg University, Heidelberg, Germany.
Joachim WittbrodtCOS Heideberg, Heidelberg University, Heidelberg, Germany.
Steffen ScholppInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Gary DavidsonInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany gary.davidson@kit.edu.
Karlsruhe Institute of Technology · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-density lipoprotein receptor-related proteins 5 and 6 (LRP5/6) function as transmembrane receptors to transduce Wnt signals. A key mechanism for signalling is Wnt-induced serine/threonine phosphorylation at conserved PPPSPxS motifs in the LRP6 cytoplasmic domain, which promotes pathway activation. Conserved tyrosine residues are positioned close to all PPPSPxS motifs, which suggests they have a functional significance. Using a cell culture-based cDNA expression screen, we identified the non-receptor tyrosine kinases Src and Fer as novel LRP6 modifiers. Both Src and Fer associate with LRP6 and phosphorylate LRP6 directly. In contrast to the known PPPSPxS Ser/Thr kinases, tyrosine phosphorylation by Src and Fer negatively regulates LRP6-Wnt signalling. Epistatically, they function upstream of β-catenin to inhibit signalling and in agreement with a negative role in regulating LRP6, MEF cells lacking these kinases show enhanced Wnt signalling. Wnt3a treatment of cells enhances tyrosine phosphorylation of endogenous LRP6 and, mechanistically, Src reduces cell surface LRP6 levels and disrupts LRP6 signalosome formation. Interestingly, CK1γ inhibits Fer-induced LRP6 phosphorylation, suggesting a mechanism whereby CK1γ acts to de-represses inhibitory LRP6 tyrosine phosphorylation. We propose that LRP6 tyrosine phosphorylation by Src and Fer serves a negative regulatory function to prevent over-activation of Wnt signalling at the level of the Wnt receptor, LRP6.

Indexed as

beta CateninCell LineHumansIn Situ HybridizationLow Density Lipoprotein Receptor-Related Protein-6Mass SpectrometryPhosphorylationProtein-Tyrosine KinasesSignal Transductionsrc-Family KinasesTyrosineWnt Proteinsbeta CateninLow Density Lipoprotein Receptor-Related Protein-6LRP6 protein, humanProtein-Tyrosine Kinasesproto-oncogene protein c-fes-fpssrc-Family KinasesTyrosineWnt ProteinsFerLRP6SrcWnt

Identifiers

PMID25391905
PMCPMC4264928
OpenAlexW2108689588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.